The Carnitine Shuttle Pathway Is Altered in Patients With Neovascular Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.18-25137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2017English

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports
2019English

Neovascular Age-Related Macular Degeneration Is Associated With Cataract Surgery

Acta Ophthalmologica
MedicineOphthalmology
2017English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

New Neovascular Age-Related Macular Degeneration Is Associated With Systemic Leucocyte Activity

Acta Ophthalmologica
MedicineOphthalmology
2016English

Pss62 - Treatment Preference Drivers of Patients With Neovascular Age-Related Macular Degeneration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)

BMC Geriatrics
GerontologyGeriatrics
2010English

IL-18 Is Not Therapeutic for Neovascular Age-Related Macular Degeneration

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy